Does NATALIZUMAB Cause Central venous catheterisation? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Central venous catheterisation have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.1% of all adverse event reports for NATALIZUMAB.
57
Reports of Central venous catheterisation with NATALIZUMAB
0.1%
of all NATALIZUMAB reports
1
Deaths
30
Hospitalizations
How Dangerous Is Central venous catheterisation From NATALIZUMAB?
Of the 57 reports, 1 (1.8%) resulted in death, 30 (52.6%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
GLYCINE\MANNITOL\SODIUM (56)
Which NATALIZUMAB Alternatives Have Lower Central venous catheterisation Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK